Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer

Lung Cancer

Volumn 53, Issue 2, 2006, Pages 217-229

  Manser, Renee L ^a,b   Wright, Gavin ^a   Byrnes, Graham ^c   Hart, David ^a   Conron, Matthew ^a   Carter, Rob ^c   McLachlan, Sue Anne ^a   Campbell, Donald A ^d  

^a ST VINCENT S HOSPITAL   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

Author keywords

Cost utility; Lung cancer; Multi attribute utility instrument; Non small cell lung cancer; Quality of life; Questionnaire; Utility

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; ASSESSMENT OF QUALITY OF LIFE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; COST UTILITY ANALYSIS; FEMALE; HUMAN; INTERNAL CONSISTENCY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36;

AGED; ANALYSIS OF VARIANCE; AUSTRALIA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SICKNESS IMPACT PROFILE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33745593962     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.05.002     Document Type: Article

References (52)

1. Montazeri A., Gillis C.R., and McEwan J. Quality of life in patients with lung cancer: a review of literature from 1970 to 1995. Chest 113 (1998) 467-481
2. Bergman B., Aaronson N.K., Ahmedzai S., Kaasa S., and Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 30 (A) (1994) 635-642
3. Anderson H., Hopwood P., Stephens R.J., Thatcher N., Cottier B., Nicholson M., et al. Gemcitabine plus best supportive care (BSC) vs. BSC in inoperable non-small cell lung cancer-a randomized trial with quality of life as the primary outcome. Br J Cancer 83 4 (2000) 447-453
4. Torrance G. Utility approach to measuring health-related quality of life. J Chron Dis 40 6 (1987) 593-600
5. Tengs T., and Wallace A. One thousand quality-of-life estimates. Med Care 38 (2000) 583-637
6. Earle C., Chapman R.H., Baker C.S., Bell C.M., Stone P.W., Sandberg E.A., et al. Systematic overview of cost-utility assessments in oncology. J Clin Oncol 18 18 (2000) 3302-3317
7. Trippoli S., Vaiani M., Lucioni C., and Messori A. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-Life Study Group of the Master 2 Project in Pharmacoeconomics. Pharmacoeconomics 19 18 (2001) 855-863
8. Marshall D., Simpson K.N., Earle C.C., and Chu C. Economic decision analysis model of screening for lung cancer. Eur J Cancer 37 14 (2001) 1759-1767
9. Raab S., and Hornberger J. The effect of patient's risk taking attitude on the cost effectiveness of testing strategies in the evaluation of pulmonary lesions. Chest 111 6 (1997) 1583-1590
10. Mahadevia P., Fleisher L.A., Frick K.D., Eng J., Goodman S.N., and Powe N.R. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA 289 3 (2003) 313-322
11. Hollen P., Gralla R.J., Kris M.G., Cox C., Belani C.P., Grunberg S.M., et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer 73 (1994) 2087-2098
12. Cella D., Bonomi A.E., Lloyd S.R., Tulsky D.S., Kaplan E., and Bonomi P. Reliability and validity of the functional assessment of cancer therapy-lung (FACT-L) quality of life instrument. Lung Cancer 12 (1995) 199-220
13. Sarna L., Padilla G., Holmes C., Tashkin D., Brecht M.L., and Evangelista L. Quality of life of long-term survivors of non-small cell lung cancer. J Clin Oncol 20 13 (2002) 2920-2929
14. Schag C., Ganz P.A., Wing D.S., Sim M.-S., and Lee J.J. Quality of life in adult survivors of lung, colon, and prostate cancer. Qual Life Res 3 (1994) 127-141
15. Myrdal G., Valtysdottir S., Lambe M., and Stahle E. Quality of life following lung cancer surgery. Thorax 58 3 (2003) 194-197
16. Mangione C., Goldman L., Orav E.J., Marcantonio E.R., Pedan A., Ludwig L.E., et al. Health related quality of life after elective surgery: measurement of longitudinal changes. J Gen Intern Med 12 11 (1997) 686-697
17. Handy J., Asaph J.W., Skokan L., Reed C.E., Koh S., Brooks G., et al. What happens to patients undergoing lung cancer surgery: outcomes and quality of life before and after surgery. Chest 122 (2002) 21-30
18. Montazeri A., Milroy R., Hole D., McEwen J., and Gillis C.R. Quality of life in lung cancer patients: an important prognostic factor. Lung Cancer 31 2-3 (2001) 233-240
19. Richardson J. Cost utility analysis: what should be measured?. Soc Sci Med 39 1 (1994) 7-21
20. Drummond M., O'Brien B., Stoddart G.L., and Torrance G.W. Cost-utility analysis. Methods for the economic evaluation of health care programmes. 2nd ed. (1997), Oxford University Press, New York [Chapter 6], p. 139-204
21. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 33 5 (2001) 328-336
22. Kaplan R., Bush J.W., and Berry C.C. Health status index: category rating versus magnitude estimation for measuring levels of well-being. Med Care 27 (1979) 501
23. EuroQoL Group. EuroQoL-a new facility measurement of health-related quality of life. Health Policy 16 (1990) 199-208
24. Torrance G., Feeny D.H., Furlong W.J., Barr R.D., Zhang Y., and Wang Q. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care 34 (1996) 702-722
25. Nord E., Richardson J., and Macarounas-Kirchmann K. Social evaluation of health care versus personal evaluation of health states. Evidence on the validity of four health-state scaling instruments using the Norwegian and Australian surveys. Int J Technol Assess Health Care 9 4 (1993) 463-478
26. Hawthorne G., Richardson J., and Osborne R. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 8 3 (1999) 209-224
27. Osborne R., Hawthorne G., Lew E.A., and Gray L.C. Quality of life assessment in the community-dwelling elderly: validation of the Assessment of Quality of Life (AQoL) Instrument and comparison with the SF-36. J Clin Epidemiol 56 (2003) 138-147
28. Sturm J., Osborne R.H., Dewey H.M., Donnan G.A., Macdonell R.A.L., and Thrift A.G. Brief comprehensive quality of life assessment after stroke: the assessment of quality of life instrument in the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 33 (2002) 2888-2894
29. Buccheri G., Ferrigno D., and Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective longitudinal study of 536 patients from a single institution. Eur J Cancer 32A 7 (1996) 1135-1141
30. Ware J., and Sherbourne C.D. The MOS 36-item Short Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
31. Hawthorne G, Richardson J, Day N. Using the Assessment of Quality of Life (AQoL) Instrument Version 1.0. West Heidelberg, Vic., Australia: Centre for Health Program Evaluation; 2000. Report No.: Technical Report 12.
32. Ware Jr. J., Kosinski M., and Gandek B. SF-36 health survey: manual and interpretation guide (2000), Quality Metric Incorporated, Lincoln, RI
33. Sanson-Fisher R., and Perkins J.J. Adaptation and validation of the SF-36 Health Survey for use in Australia. J Clin Epidemiol 51 11 (1998) 961-967
34. Australian Bureau of Statistics. SF-36 population norms. Canberra: Australian Bureau of Statistics; 1995.
35. Stata Corporation. Stata. In: 6.0 for Windows ed. Texas; 1999.
36. Altman D. Principles of statistical analysis. Practical statistics for medical research (1991), Chapman and Hall, London [Chapter 8], p. 152-78
37. Streiner D., and Norman G. Selecting the items. Health measurement scales: a practical guide to their development and use. 2nd ed. (1995), Oxford University Press, Oxford [Chapter 5], p. 54-68
38. Guyatt G., Feeny D.H., and Patrick D.L. Measuring health-related quality of life. Ann Intern Med 118 (1993) 622-629
39. Streiner D., and Norman G. Validity. Health measurement scales: a practical guide to their development and use. 2nd ed. (1995), Oxford University Press, Oxford [Chapter 10]
40. Altman D. Relation between several variables. Practical statistics for medical research (1991), Chapman and Hall, London [Chapter 12], p. 325-64
41. Liang M. Evaluating measurement responsiveness. J Rheumatol 22 (1995) 1191-1192
42. Liang M., Larson M.G., Cullen K.E., and Schwartz J.A. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheumatism 28 5 (1985) 542-547
43. Dales R., Belanger R., Shamji F.M., Leech J., Crepeau A., and Sachs H.J. Quality of life following thoracotomy for lung cancer. J Clin Epidemiol 47 (1994) 1443-1449
44. Ries L.A. Influence of extent of disease, histology and demographic factors on lung cancer survival in the SEER population-based data. Semin Surg Oncol 10 (1994) 21-30
45. Goumas C., O'Connell D.L., Smith D.P., and Armstrong B.K. Lung cancer in NSW in 1973-1998 (2001), The Cancer Council, NSW, Sydney
46. Department of Human Services (South Australian Cancer Registry). Epidemiology of cancer in South Australia: incidence, mortality and survival 1977 to 1999. Incidence and mortality 1999. Adelaide: Department of Human Services; 1999. Report No.: Cancer Series number 22.
47. Hawthorne G, Richardson J, Day N, Mcneil H. Life and death: theoretical and practical issues using utility instruments. West Heidelberg, Vic., Australia: Centre for Health Program Evaluation; 2000. Report No.: Working Paper 102.
48. Smith E., Hann D.M., Ahles T.A., Furstenberg C.T., Mitchell T.A., Meyer L., et al. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Sympt Manage 21 4 (2001) 323-329
49. Gridelli C., Perrone F., Nelli F., Ramponi S., and De Marinis F. Quality of life in lung cancer patients. Ann Oncol 12 Suppl. 3 (2001) S21-S25
50. Lind M., Vernon C., Cruickshank D., Wilkinson P., Littlewood T., Stuart N., et al. The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer 86 8 (2002) 1243-1249
51. Brazier J., Roberts J., and Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 21 2 (2002) 271-292
52. Hawthorne G., Richardson J., and Day N.A. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med 33 5 (2001) 358-370